Physician profile
Datche Denise Walker
NPI 1619300738
$1,770.68
in general payments reported to CMS, 2019-2025
19 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $542 · 2022: $189 · 2023: $418 · 2024: $280 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $359.48 | 2021-2025 | Slynd |
| Abbvie INC. | $288.07 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $207.30 | 2022-2025 | |
| Pfizer INC. | $206.34 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.77 | 2021-2023 | Trintellix |
| Therapeuticsmd, INC. | $105.92 | 2021-2022 | |
| Organon LLC | $93.12 | 2021-2025 | Nexplanon |
| Myriad Women'S Health, INC. | $93.01 | 2023 | Myrisk |
| Shield Therapeutics INC | $60.21 | 2023-2024 | Accrufer |
| Lupin INC. | $50.24 | 2021 | |
| Scynexis, INC. | $35.52 | 2022 | |
| Sage Therapeutics, LLC | $22.90 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $22.07 | 2024 | Myfembree |
| Astellas Pharma US INC | $20.83 | 2024 | Veozah |
| Daiichi Sankyo INC. | $19.93 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.57 | 2024 | Novasure, Myosure Tissue Removal Device |
| Smith+Nephew, INC. | $15.11 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.77 | 2022 | |
| Evofem Biosciences, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Datche Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.